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ABSTRACT: 
Increased resistance of MRSA (multidrug resistance Staphylococcus aureus) to anti-
infective drugs is a threat to global health necessitating the development of anti-infectives with 
novel mechanisms of action. Phenylalanine tRNA synthetase (PheRS) is a unique enzyme of the 
aminoacyl-tRNA synthetases (aaRSs), which are essential enzymes for protein biosynthesis. 
PheRS is an (αβ)2 tetrameric enzyme composed of two alpha subunits (PheS) and two larger beta 
subunits (PheT). Our potential target in the drug development for the treatment of MRSA 
infections is the phenylalanine tRNA synthetase alpha subunit that contains the binding site for 
the natural substrate. There is no crystal structure available for S. aureus PheRS, therefore 
comparative structure modeling is required to establish a putative 3D structure for the required 
enzyme enabling development of new inhibitors with greater selectivity. The S. aureus PheRS 
alpha subunit homology model was constructed using Molecular Operating Environment (MOE) 
software. Staphylococcus haemolyticus PheRS was the main template while Thermus 
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thermophilus PheRS was utilised to predict the enzyme binding with tRNAphe. The model has 
been evaluated and compared with the main template through Ramachandran plots, Verify 3D 
and Protein Statistical Analysis (ProSA). The query protein active site was predicted from its 
sequence using a conservation analysis tool. Docking suitable ligands using MOE into the 
constructed model was used to assess the predicted active sites. The docked ligands involved the 
PheRS natural substrate (phenylalanine), phenylalanyl-adenylate and several described S. aureus 
PheRS inhibitors.  
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INTRODUCTION 
The aminoacyl tRNA synthetases (aaRSs) are essential enzymes for protein biosynthesis 
that catalyse the attachment of an amino acid to its cognate tRNA molecule in a two-step 
reaction. Cognate amino acids first react with ATP forming aminoacyl-adenylate, these activated 
forms of the amino acids are subsequently attached to their cognate tRNA by esterification. The 
catalytic steps are based on the ability of aaRSs to recognise amino acids, ATP and cognate 
tRNA for proper transformation of genetic information into proteins (1). Inhibition of either one 
of these stages results in accumulation of uncharged tRNA molecules, which bind to ribosomes 
causing interruption of polypeptide chain elongation and ultimately inhibition of protein 
synthesis (2). The aaRSs are categorised into two classes according to the structural features of 
the enzymes. Class I enzymes contain a Rossman fold in the catalytic core and two conserved 
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motifs, called HIGH and KMSKS. Class II enzymes have an antiparallel β-sheet with three 
conserved motifs in the catalytic centre (1, 3).  
Increased resistance to anti-infective drugs is a threat to global health; hence anti-
infective agents with novel mechanisms must be developed. S. aureus was chosen as MRSA is a 
growing problem in shared facilities such as hospitals, healthcare facilities and nursing homes. 
Studies indicate that the incidence of MRSA in the past few years have extensively increased 
worldwide. However, there are considerable differences between various countries. Whereas in 
the USA, Japan and southern European countries a high prevalence of MRSA between 20 and 
60% exists, the prevalence in the Netherlands and Scandinavian countries is less than three 
percent (4). 
AaRS provide a valuable target in bacterial protein biosynthesis, to date only one drug, 
mupirocin, which inhibits a specific type of aaRS (IleRS), has been licensed as a topical 
antibiotic for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) (5). Since 
each amino acid requires an aaRS there is a potential wealth of targets suitable for rational drug 
design. The research described here focuses on PheRS. This target was selected because it is 
structurally unique among the aaRS enzymes and considerably different from human cytosolic 
and human mitochondrial aaRS, with 29.5% homology for PheRS and 20.6% homology for 
PheRS(Supplementary Table S1). Phenylalanine tRNA synthetase (PheRS) is an (αβ)2 
tetrameric enzyme composed of two alpha subunits (PheS) and two larger beta subunits (PheT). 
According to the structure, PheRS is classified as a class II aaRSs as its catalytic domain is built 
around antiparallel β-sheets but functionally it resembles class I because it aminoacylates the 2’ 
OH of the terminal ribose of tRNA whereas class II aminoacylate the 3’ OH (6, 7). 
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There is no crystal structure available for S. aureus PheRS, therefore a homology model 
was constructed and subsequently structure and active site architecture analysed. 
 
METHODS 
Construction of the S.aureus PheS model 
Homology search 
The protein sequence for the alpha subunit (PheS) of S. aureus PheRS was obtained from the 
ExPASy proteomics server at the Swiss Bioinformatics Institute (8). The enzyme sequence for 
the alpha subunit has the Uniprot identifier P68849 (SYFA_STAAU) and is composed of 352 
residues (9). Only PheS was used for the homology model construction as it contains the 
catalytic domain of the enzyme.  
A homology search was performed using the SIB BLAST service (10, 11) accessible from the 
ExPASy server, which was used to align the query sequence (PheS) against the sequences in the 
protein data bank (12) and thus the close homologous proteins were identified. The alignment 
parameters and the thresholds, which were used for screening expected homologues, were used 
with their default values and BLOSUM62 comparison matrix. The phylogeny server (13) was 
used to build a phylogenetic tree for these homologous proteins, the query sequence and other 
PheS enzymes selected from different organisms.   
Multiple sequence and structure alignment 
The sequence of the query enzyme was aligned with the protein sequences of the most related 
PheRS templates: Staphylococcus haemolyticus (pdb: 2RHQ), Pseudomonas aeruginosa (pdb: 
4P71), Escherichia coli (pdb: 3PCO) and Thermus thermophilus (pdb: 1PYS), using Clustal 
Omega 1.2.2 (14), as the local alignment of these sequences would reveal the most conserved 
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residues and the common features and motifs: motif 1, motif 2 and motif 3. This could be used to 
understand some of the expected structural and functional similarity between these enzymes. The 
secondary structure of S. aureus and the closest template (2RHQ) were determined using 
PSIPRED v3.3 (15). 
3D model building 
The molecular experiments were performed using Molecular Operating Environment (MOE) 
2014.0901 molecular modeling software (16). Homology models were built using MOE-
Homology using AMBER99 forcefield (17), which uses a dictionary to set the partial charges of 
atoms in amino acids. The final homology model was constructed using S. haemolyticus PheS 
(2RHQ) crystal structure. Ten intermediate models were generated and the final model was taken 
as the Cartesian average of all the intermediate models. All minimisations were performed until 
RMSD gradient of 0.05 kcal mol-1Å-1 with the specified forcefield and partial charges 
automatically calculated. 
Model validation 
Stereochemical quality of the polypeptide backbone and side chains was evaluated using 
Ramachandran plots obtained from the RAMPAGE server (18). The compatibility of the 3D 
model with its own amino acid 1D sequence was examined using Verify 3D (19). The ProSA 
server (20) was used to check defaults in the three dimensional protein structure based on 
statistical analysis. Validation data from the template (2RHQ) was used as the baseline to 
evaluate the model. 
Docking 
Phenylalanine as the natural substrate, phenylalanyl-adenylate (21) and known inhibitors with 
reported microbiological activity were built as ligands using MOE-Builder (22, 23), and the 
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energy was minimised for each ligand. These ligands were docked by running MOE-Dock with 
default setting: Placement: Triangular Matcher, Rescoring 1: London G, 30 poses were 
constructed for each compound and the best scoring model-ligand complexes were selected. The 
ligand interactions within the constructed model were visualised using the MOE ligand 
interaction simulation.  
 
Results and discussion 
Homology model and validation 
Initial screening for possible templates was performed using a BLAST analysis (10) of the amino 
acid sequence of S. aureus PheS, obtained from the ExPASy proteomics server (8), against the 
PDB resolved structures, four structures were identified for consideration as possible templates 
(Table 1).  
Table 1 The first four hits in the S. aureus PheRS-α subunit BLAST results 
Organism PDB code BLASTa 
score 
Sequence 
identityb 
Sequence 
identity% 
Positive 
% 
Chain 
length 
E-
Value 
Staphylococcus 
haemolyticus 
2RHQ 536 250/268 93 98 294 0.0 
Pseudomonas 
aeruginosa 
4P71 372 177/340 52 69 338 5e-127 
Escherichia coli 3PCO 341 169/338 50 67 327 5e-115 
Thermus 
thermophilus 
1PYS 270 147/359 41 60 350 5e-87 
a The BLAST score for an alignment is calculated by summing the scores for each aligned position and the scores 
for gaps. b (Number of identical residues)/(length of sequence fragment identified by PSI-BLAST). 
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For a structure to be considered a template, it should be wild-type, rather than mutant or 
engineered, have a reasonable sequence identity with S. aureus PheRS and also have the same 
function. The first four native hits are bacterial PheRS enzymes. The PheRS enzyme of 
Staphylococcus haemolyticus (24) was the best template due to very high sequence identity 
(93%). 
 
Figure 1 The phylogenetic tree of S. aureus PheS in relation to PheS enzyme from other 
organisms: Saccharomyces cerevisiae (yeast) (P15625); human (Q9Y285); mouse (Q8C0C7); 
zebra fish (Q1JPX3); African clawed frog (Q6AZG6); Mycobacterium tuberculosis (P9WFU3); 
Thermus thermophilus (Q5SGX2); Pseudomonas aeruginosa (Q9I0A3); Escherichia coli 
(P08312); Enterococcus faecalis (Q836J6); Streptococcus pyogenes (Q9A0I1); Bacillus subtilis 
(P17921); Staphylococcus aureus (P68849) and Staphylococcus haemolyticus (Q4L5E3). 
 
To obtain more information related to the best possible template, the phylogeny server 
(13) was used to construct a phylogenetic tree using PheRS protein sequences from different 
organisms to determine the relative distances between the these enzyme and the query sequence 
(Fig. 1).  The phylogenic tree demonstrates the different evolutionary branching of the 
prokaryotic and eukaryotic PheRS enzyme. The closest homologies to S. aureus in this group of 
species are: the Gram-positive bacteria S. haemolyticus (STAHJ) followed by Bacillus subtillis 
(BACSU), Enterococcus feacalis (ENTFA) and Streptococcus pyogenes (STRP1) respectively. 
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A lower homology is observed with the Gram-negative E. coli and with Mycobacterium 
tuberculosis, with clear difference observed for non-bacterial organisms in agreement with the 
phylogenic tree. Clustal analysis and percent identity (Supplementary Fig. S2 and S3) provide 
further validation.  
 
Multiple Sequence and structural alignments 
Clustal Omega 1.2.2 (14) was used to align the preferred template sequences and the query 
sequence of S. aureus PheS (Fig. 2). Conservation was clearly observed between most of the 
residues of the query sequence and the closely related template S. haemolyticus. 
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Figure 2 Sequence alignment of PheS enzymes of Thermus thermophilus, Staphylococcus 
aureus, Staphylococcus haemolyticus, Pseudomonas aeruginosa and Escherichia Coli using 
Clustal O in which "*" means that the residues are identical, ":" means that conserved 
substitutions have been observed, "." means that semi-conserved substitutions are observed. The 
residues are coloured according to their chemical properties where red, small hydrophobic 
(AVFPMILWY); blue, acidic (DE); purple, basic (RHK); green, hydroxyl + amine + basic 
(STYHCNGQ). 
CLUSTAL O(1.2.3) multiple sequence alignment
sp|Q5SGX2|SYFA_THET8      ---------MLEEALAAIQNARDLEELKALKARYLGKKGLLTQEMKGLSALPLEERRKRG 51
sp|P68849|SYFA_STAAU      MSEQQTMSELKQQALVDINEANDERALQEVKVKYLGKKGSVSGLMKLMKDLPNEEKPAFG 60
sp|Q4L5E3|SYFA_STAHJ      MTQNDSMAELKQQALVDINEAQNERELQDVKVKYLGKKGSVSGLMKNMKDLPNEEKPAYG 60
sp|Q9I0A3|SYFA_PSEAE      ---MENLDALVSQALEAVRHTEDVNALEQIRVHYLGKKGELTQVMKTLGDLPAEERPKVG 57
sp|P08312|SYFA_ECOLI      ---MSHLAELVASAKAAISQASDVAALDNVRVEYLGKKGHLTLQMTTLRELPPEERPAAG 57
                                   :  .*   : .: :   *. ::..****** ::  *. :  ** **:   *
sp|Q5SGX2|SYFA_THET8      QELNAIKAALEAALEAREKALEEAALKEALERERVDVSLPGASLFSGGLHPITLMERELV 111
sp|P68849|SYFA_STAAU      QKVNELRQTIQNELDERQQMLVKEKLNKQLAEETIDVSLPGRHIEIGSKHPLTRTIEEIE 120
sp|Q4L5E3|SYFA_STAHJ      QKVNELRQTIQKELDEKQELLKNEKLNQQLAEETIDVTLPSRQISIGSKHPLTRTVEEIE 120
sp|Q9I0A3|SYFA_PSEAE      ALINVAKEKVQDVLNARKTELEGAALAARLAAERIDVTLPGRGQLSGGLHPVTRTLERIE 117
sp|P08312|SYFA_ECOLI      AVINEAKEQVQQALNARKAELESAALNARLAAETIDVSLPGRRIENGGLHPVTRTIDRIE 117
                            :*  :  ::  *: ::  *    *   *  * :**:**.     *. **:*    .: 
                                                                              Motif 1
sp|Q5SGX2|SYFA_THET8      EIFRALGYQAVEGPEVESEFFNFDALNIPEHHPARDMWDTFWLTGEGFRLEGPLGEEVEG 171
sp|P68849|SYFA_STAAU      DLFLGLGYEIVNGYEVEQDHYNFEMLNLPKSHPARDMQDSFYITD--------------- 165
sp|Q4L5E3|SYFA_STAHJ      DLFLGLGYEIVDGYEVEQDYYNFEALNLPKSHPARDMQDSFYITD--------------- 165
sp|Q9I0A3|SYFA_PSEAE      QCFSRIGYEVAEGPEVEDDYHNFEALNIPGHHPARAMHDTFYFNA--------------- 162
sp|P08312|SYFA_ECOLI      SFFGELGFTVATGPEIEDDYHNFDALNIPGHHPARADHDTFWFDT--------------- 162
                          . *  :*:  . * *:*.:..**: **:*  ****   *:*::                 
sp|Q5SGX2|SYFA_THET8      RLLLRTHTSPMQVRYMVAH--TPPFRIVVPGRVFRFEQTDATHEAVFHQLEGLVVGEGIA 229
sp|P68849|SYFA_STAAU      EILLRTHTSPVQARTMESRHGQGPVKIICPGKVYRRDSDDATHSHQFTQIEGLVVDKNVK 225
sp|Q4L5E3|SYFA_STAHJ      EILMRTHTSPVQARTMEKRNGQGPVKIICPGKVYRRDSDDATHSHQFTQIEGLVVDKNIK 225
sp|Q9I0A3|SYFA_PSEAE      NMLLRTHTSPVQVRTMESQ--QPPIRIVCPGRVYRCDSD-LTHSPMFHQVEGLLVDEGVS 219
sp|P08312|SYFA_ECOLI      TRLLRTQTSGVQIRTMKAQ--QPPIRIIAPGRVYRNDYD-QTHTPMFHQMEGLIVDTNIS 219
                            *:**:** :* * *  :    *.:*: **:*:* :    **   * *:***:*. .: 
                                                            Motif 2
sp|Q5SGX2|SYFA_THET8      MAHLKGAIYELAQALFGPDSKVRFQPVYFPFVEPGAQFAVWW----------PEGGKWLE 279
sp|P68849|SYFA_STAAU      MSDLKGTLELLAKKLFGADREIRLRPSYFPFTEPSVEVDVSCFKCKGKGCNVCKHTGWIE 285
sp|Q4L5E3|SYFA_STAHJ      MSDLKGTLELVAKKLFGADREIRLRPSYFPFTEPSVEVDVSCFKCKGKGCNVCKHTGWIE 285
sp|Q9I0A3|SYFA_PSEAE      FADLKGTIEEFLRAFFEKQLEVRFRPSFFPFTEPSAEVDIQCVICSGNGCRVCKQTGWLE 279
sp|P08312|SYFA_ECOLI      FTNLKGTLHDFLRNFFEEDLQIRFRPSYFPFTEPSAEVDVM-----------GKNGKWLE 268
                          ::.***::  . : :*  : ::*::* :***.**..:. :             :   *:*
                                                                   zinc binding
sp|Q5SGX2|SYFA_THET8      LGGAGMVHPKVFQAVDAYRERLGLPPAYRGVTGFAFGLGVERLAMLRYGIPDIRYFFGGR 339
sp|P68849|SYFA_STAAU      ILGAGMVHPNVLEMAGFDS---------SEYSGFAFGMGPDRIAMLKYGIEDIRHFYTND 336
sp|Q4L5E3|SYFA_STAHJ      ILGAGMVHPNVLEMAGFDS---------NEYSGFAFGMGPDRIAMLKYGIEDIRYFYTND 336
sp|Q9I0A3|SYFA_PSEAE      VMGCGMVHPNVLRMSNIDP---------EKFQGFAFGMGAERLAMLRYGVNDLRLFFDND 330
sp|P08312|SYFA_ECOLI      VLGCGMVHPNVLRNVGIDP---------EVYSGFAFGMGMERLTMLRYGVTDLRSFFEND 319
                          : *.*****:*:.  .                *****:* :*::**:**: *:* *: . 
                                                                   Motif 3
sp|Q5SGX2|SYFA_THET8      LKFLEQFKGVL----- 350
sp|P68849|SYFA_STAAU      VRFLDQFKAVEDRGDM 352
sp|Q4L5E3|SYFA_STAHJ      VRFLEQFKAVEDRGEA 352
sp|Q9I0A3|SYFA_PSEAE      LRFLGQFR-------- 338
sp|P08312|SYFA_ECOLI      LRFLKQFK-------- 327
                          ::** **:
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The PheRS α-subunit contains three conserved sequence motifs  (motif 1, motif 2 and motif 3), 
which are typical for class II aminoacyl tRNA synthetases (9). These motifs play an important 
role in the aminoacylation process, as they are responsible for active site formation. In this active 
pocket, binding occurs with ATP/phenylalanine as well as interaction with the acceptor stem of 
tRNAphe. All the residues in motifs 1, 2 and 3 that form the active site in both S. aureus and S. 
haemolyticus are conserved. PSIPRED (15) secondary structure prediction for S. aureus PheS 
showed that motif 1 (110-136) contained a high helix content surrounded by a short strand and 
coil, motif 2 (196-218) folds mainly in coils and short helix and strands and motif 3 (310-330) at 
the C terminal of the α-subunit clearly folds to coils and helices. The crystal structure of S. 
haemolyticus (2RHQ) shows these folds indicating good agreement with the predictions of 
PSIPRED for the query sequence (Supplementary data Fig. S4). 
 
3D homology model and validation 
The homology model was constructed using S. haemolyticus PheRS-α subunit (2RHQ) 
crystal structure through Molecular Operating Environment (MOE) software. The constructed 
model was subjected to a number of checks to assess its quality. Stereochemical quality was 
evaluated by Ramachandran plots using the RAMPAGE server (18) and the compatibility of the 
3D model with its own amino acid 1D sequence was validated using Verify 3D (19). Overall 
protein structure was evaluated using ProSA (20). 
Validation results would propose that the model performed well in terms of the backbone 
stereochemistry and amino acid environment. In the Ramachandran plot, a total of 99.7% of the 
residues were in the allowed region, which compared well with the template 2RHQ (98.9%), 
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revealing that the main chain dihedral ϕ and ψ angles in the model were reasonably accurate 
(Supplementary Fig. S1). Only one amino acid residue (Gly272) was found in the outlier region 
in the model, which is away from the active site and would not be expected to affect enzyme 
function (Fig. 9). 
Verify 3D evaluated three parameters for each amino acid, which are secondary structure, 
degree of buried surface area and fraction of side chain area that is covered by polar atoms. 
These three parameters were evaluated for each residue in the structure and a correlation was 
calculated between this set of observed parameters and the ideal parameters of the amino acid 
type to which it has been assigned. Verify 3D should stay above 0.2 and not fall under zero (19). 
The percentage of residues, which are more than 0.2 was 85.25% and 87.77% for the model and 
the template, respectively. However, the percentage of residues that are less than zero was 9.71% 
and 7.04% for the model and the template, respectively. The model residues that fall under zero 
are the first 27 residues, which are away from the active site.  
Protein statistical analysis (ProSA) provides two plots; the first (Fig. 3a) shows the local 
model quality by plotting energies as a function of amino acid sequence position, generally 
positive values relate to erroneous parts of the input structure. The second plot (Fig. 3b) indicates 
overall model quality from which the z-score is calculated, its value is displayed in a plot which 
has the z-scores of all experimentally determined protein chains in the current PDB determined 
by X-ray crystallography or NMR spectroscopy, a negative score shows a good model while a 
positive value would shows errors. The z-score of the model was -7.72 compared with the z-
score of the template 2RHQ which was -7.73. 
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Figure 3 ProSA output for the S. aureus PheRS-α subunit model. a: shows the local model 
quality by plotting energies as a function of amino acid sequence position. b: shows the overall 
model quality by calculating z-score (dark spot). 
 
Moreover, superimposition of the model with the main template (2RHQ) using MOE showed a 
low RMSD of 0.960 Å indicating a high degree of similarity. 
Model validation using Ramachandran plot, Verify 3D and ProSA indicated a good model in 
terms of quality of backbone and side-chain stereochemistry for S. aureus PheS. Further 
validation of the active site architecture was performed by natural substrate and ligand docking 
experiments. 
 
Active site validation and docking 
Validation of the predicted active site was assessed through Clustal O multiple sequence 
alignment, the MOE alignment service and by docking known ligands into the constructed 
model.  The active site is a large hydrophobic pocket formed by the following residues Leu148, 
His152, Ala154, Asp159, Ser160, Thr171, His172, Ser174, Gln177, Met181, Arg200, Phe212, 
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Gln214, Glu216, Leu218, Tyr253, Phe254, Pro255, Phe256, Thr257, Glu285, Leu287, Ile286, 
Gly288, Ala289, Gly290, Val292, Val296, Ala311, Phe312, Gly313 and Arg318. Characteristic 
with other bacterial enzymes, one wall of the phenylalanine binding pocket contains amino acids 
that can participate in hydrogen bonding and electrostatic interaction while the opposite was 
contains mainly hydrophobic amino acids (25). Through docking of the natural ligand, 
phenylalanine, hydrogen bonding interaction of the phenylalanine positively charged amine 
group and the acidic amino acid Glu216 was observed (Table 2) on one face of the pocket, while 
recognition on the hydrophobic side of the active site is via two phenylalanine residues, Phe254 
and Phe256, from the eubacteria-specific FPF loop (25). 
In contrast the FPF triad is absent from the phenylalanine active site in all eukaryotic PheRS, in 
human PheRS a triplet of residues Asn410, Pro411 and Tyr412 replace the FPF loop 
(Supplementary Fig. S2) (26). This difference can be exploited in selective drug design. 
 
Table 2 3D and 2D models of binding interactions of phenylalanine in S. aureus PheRS active 
site 
3D structure 2D ligand interactions 
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Table 3 3D and 2D models of binding interactions of phenylalanyl-adenylate in S. aureus PheRS 
active site 
3D structure 2D ligand interactions 
 
 
 
The same hydrogen bonding interaction between the amino group of phenylalanine and the 
acidic Glu216 was noted as a key binding interaction on docking phenylalanyl-adenylate (21) as 
well as hydrogen bonding interaction with Ser174, with the adenylate moiety positioned further 
along the hydrophobic pocket channel. The adenine ring may form -stacking interactions with 
Phe212 and an additional H-boning interaction between the adenine amino group and Ala154 
may help with correct orientation in the active site (Table 3). 
Two classes of S. aureus PheRS inhibitors were investigated through docking studies, phenyl-
thiazolylurea-sulfonamides (22) and ethanolamine derivatives (23). As observed for 
phenylalanine and phenylalanyl-adenylate, the acidic amino acid residue Glu216 forms H-
bonding interaction with the ligands acting as an anchor and directing correct orientation within 
the hydrophobic pocket. Interaction between Glu216 and the phenyl-thiazolylurea-sulfonamides 
was though the urea NH moiety and/or the thiazoyl sulfur group (Table 4), while for the 
ethanolamine derivatives the interaction was observed via the ethanolamine OH or NH of the 
linker chain (Table 5).  
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Table 4 Representative 3D and 2D models of binding interactions of phenyl-thiazolylurea-
sulfonamides in S. aureus PheRS active site. 
3D structure 2D ligand interactions 
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Table 5 Representative 3D and 2D models of binding interactions of ethanolamine inhibitors in 
S. aureus PheRS active site 
3D structure 2D ligand interactions 
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Additional H-bonding interactions observed for some of the inhibitors and the enzyme active site 
included interactions with Ala154, His172, Ser174, Phe256, Glu285 and Gly288. The binding 
mode in the S. aureus PheS model was comparable with the binding of ligands in S. 
haemolyticus (2RHQ); indicating the conservation of active site key residues. 
 
Metal Binding 
Zinc metal 
An experimental study on S. haemolyticus PheRS by Artem et al. (24) suggested that a zinc 
finger is present, with residues in the region of Ser266 to Gly282 forming a compact metal 
binding site where the four sulfur ligands related to Cys267, Cys270, Cys275 and Cys278 form a 
tetrahedral coordination with zinc (Fig. 4). 
 
Figure 4 Zinc binding site in S. haemolyticus PheRS-α subunit (http://www.ebi.ac.uk/pdbe) 
 
All PheRS-α subunit proteins from Gram-positive organisms have a conserved sequence 
insertion in the vicinity of residue 270. Within this insertion, there are the four cysteine residues 
which bind to zinc metal (Fig. 2). This was supported by the alignment of S. aureus PheRS α-
subunit with the suggested template where all four conserved cysteine residues are identified in 
the region of this domain in the query sequence (Fig. 5). The zinc metal is not involved in the 
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active binding site and is also positioned far from the putative tRNAphe binding domains (Fig. 
10). 
A B 
 
 
Figure 5 (A) Two dimensional form of tetrahedral coordination of zinc with four cysteine 
residues in the S. aureus PheRS-α subunit model. (B) Superimposition of S. aureus PheRs α-
subunit model residues (green) and S. haemolyticus template (2RHQ, purple) residues interacting 
with the zinc ion (grey sphere S. aureus model, cyan sphere S. haemolyticus). 
 
The metal binding site at the α/β- subunit interface 
        The magnesium ion is located at the interface between the α and β-subunits by five 
electrostatic interactions with acidic residues Asp β452, Glu β461 and Glu β462 from the beta 
subunit and with Glu α262 from the alpha subunit in proximity to the active site. Moreover, there 
is a sixth weak interaction of the metal ion with the carbonyl-oxygen atom of Asp β458 (27). 
Two magnesium ions are present per (αβ)2 tetramer. The metal-mediated residues are conserved 
in T. thermophilus, S. haemolyticus and S. aureus (Table 6). Although the alpha subunit is 
responsible for the catalytic activity for binding with ATP/phenylalanine, biochemical studies 
(27) have shown that the alpha subunit is not able to catalyse the first step of the reaction in the 
absence of the beta subunit. 
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Table 6 Amino acids responsible for magnesium binding at the α/β- subunit interface 
Thermus thermophilus Staphylococcus haemolyticus Staphylococcus aureus 
Asp β452 Asp β 461 Asp β 461 
Asp β 458 (via carbonyl- 
oxygen) 
Asp β 467 (via carbonyl-
oxygen) 
Asp β 467 (via carbonyl-
oxygen) 
Glu β 461 Glu β 470 Glu β 470 
Glu β 462 Glu β 471 Glu β 471 
Glu α 262 Glu α 258 Glu α 258 
   
Recognition and binding of PheRS with cognate tRNAphe   
The tRNA crystal structure binding with S. haemolyticus PheRS is not available therefore; 
tRNAphe binding with S. aureus PheRS has been predicted from the published X-ray structure of 
Thermus thermophilus PheRS complexed with tRNAphe (21, 28, 29). From the published crystal 
structure of Thermus thermophilus, it was found that the β-subunit contains eight complex 
domains. β1 (residues 1-39 and 152-183) and β5 (residues 401-473) domains have the same 
topology comprised of helix-loop-helix motifs which exhibit interaction with certain DNA 
sequences of Thermus thermophilus genomic DNA (30). However, the S. aureus PheRS amino 
acid sequence does not show this helix-loop-helix in the corresponding area so S. aureus enzyme 
is not predicted to bind with DNA (9). The β2 domain (residues 40-151) is structurally related to 
the anticodon binding domain of the bacterial aspartyl-tRNA synthetase (31) while the β8 
domain (residues 692-785) resembles the RNA binding domain of spliceosomal protein U1A 
(32). Experimental data (26, 33) shows that the tRNAphe anticodon tends towards β8 instead of 
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β2. The β6 domain (residues 482-514 and residues 564-679) together with the β7 domain 
(residues 515-563), whose function is still ambiguous, are considered as pseudocatalytic domains 
as they are structurally related to the active site of the α-subunit (29). The β3 (residues 211-264 
and residues 329-396) and β4 (residues 265-328) domains resemble the Scr homology (SH3) 
domain, which occur in large numbers in eukaryotic tyrosine kinase but their function is still 
unknown (34). Overall, the C-terminal β8 domain is the essential one in the PheRS β-subunit for 
recognition and binding with cognate tRNAphe and other β-subunit domains have no clear role in 
the aminoacylation process. 
The PheRS enzyme binds two tRNAphe molecules. Each tRNA binds across all four 
subunits of the enzyme, which indicates the necessity of the α2β2 quaternary architecture for the 
enzyme activity (28). The CCA-end and the acceptor stem of the tRNAphe molecule interact with 
the α-subunit active site and with the N-terminal domain of the β-subunit for the same 
heterodimer. The anticodon loop of tRNAphe is recognised by the β8 domain, which is located at 
the C-terminal domain of the β*-subunit of the second heterodimer (* for the second 
heterodimer).  
 
Table 7 Homology of S. aureus and S. haemolyticus and T. thermophilus PheRS, through SIB 
BLAST service 
Organism PDB code BLAST 
score 
Sequence 
identity% 
Positive 
% 
Chain 
length 
E-
Value 
S. haemolyticus 2RHS 1258 78 90 800 0.0 
T. thermophilus 1PYS 388 34 51 785 2e-121 
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Table 7 shows homology between S. aureus, S. haemolyticus and T. thermophilus, 
through SIB BLAST service (10, 11) accessible from ExPASy server. S. aureus PheRS-β subunit 
(PheT) has the uniprot identifier Q9AGR3 (SYFB_STAAU) composed of 800 residues. 
Proposed interactions of the GAA anticodon and CCA end in tRNAphe with S. aureus 
PheRS residues are based on the Clustal alignment of both α and β-subunits for the query 
enzyme with S. haemolyticus and T. thermophilus (Fig. 2, 6) where boxed amino acids residues 
at the C terminal β8 domain in Fig. 6 are responsible for recognition and interaction with 
tRNAphe anticodon bases and also their genomic alignment of tRNAphe (Fig. 7). The sequence 
conservation degree between β-subunits for S. aureus and T. thermophilus is 34% identity and 
51% similarity. Although these percentages are lower than that between S. aureus and S. 
haemolyticus, the available T. thermophilus crystal structure was used to predict binding of 
tRNA with the enzyme, as importantly the predicted binding residues are conserved between 
PheRS of these three bacteria.   
 22 
 
Figure 6. Sequence alignment of PheT (-subunit) enzymes of Staphylococcus aureus, 
Staphylococcus haemolyticus and Thermus thermophilus, using Clustal Omega in which "*" 
means that the residues are identical, ":" means that conserved substitutions have been observed, 
"." means that semi-conserved substitutions are observed. The residues are coloured according to 
their chemical properties where red, small hydrophobic (AVFPMILWY); blue, acidic (DE); 
purple, basic (RHK); green, hydroxyl + amine + basic (STYHCNGQ). Boxed amino acid 
residues recognise the tRNAphe anticodon. 
CLUSTAL O(1.2.3) multiple sequence alignment
sp|Q5SGX1|SYFB_THET8      MRVPFSWLKAYVPELESPEVLEERLAGLGFETDRIERVFPIPRGVVF--ARVLEAHPIPG 58
sp|Q9AGR3|SYFB_STAAU      MLISNEWLKEYVTIDDSVSDLAERITRTGIEVDDLIDYTKDIKNLVVGFVKSKEKHPDAD 60
sp|Q4L5E4|SYFB_STAHJ      MLISNEWLKDYVDAGVKVEDLAERITRTGIEVDDMIDYSKDIKNLVVGYIQSKEKHPDAD 60
                          * :  .*** **    . . * **::  *:*.* :       :.:*.   :  * **  .
sp|Q5SGX1|SYFB_THET8      -TRLKRLVLDAGRTVEVVSGAENARKGIGVALALPGTELPGLGQKVGERVIQGVRSFGMA 117
sp|Q9AGR3|SYFB_STAAU      KLNVCQVDIGEDEPVQIVCGAPNVDAGQYVIVAKVGGRLPG-GIKIKRAKLRGERSEGMI 119
sp|Q4L5E4|SYFB_STAHJ      KLNICQVDIGEEEPVQIVCGAPNVDAGQHVIVAKVGGRLPG-GIKIKRAKLRGERSEGMI 119
                            .: :: :.  . *::*.** *.  *  * :*  * .*** * *: .  ::* ** ** 
sp|Q5SGX1|SYFB_THET8      LSPRELGVG------EYGGGLLEFPEDALPPGTPLSEAWPEEVVLDLEVTPNRPDALGLL 171
sp|Q9AGR3|SYFB_STAAU      CSLQEIGISSNYIPKSFESGIYVFSESQVPGTDALQALYLDDQVMEFDLTPNRADALSMI 179
sp|Q4L5E4|SYFB_STAHJ      CSLQEIGISSNVVPKAYENGIFVFQTEVEPGTDALTALYLNDQVMEFDLTPNRADALSMV 179
                           * :*:*:.       : .*:  *  .  *    *   : :: *:::::**** ***.::
sp|Q5SGX1|SYFB_THET8      GLARDLHALGYAL-VEPEAALK--AEALPLPFALKVEDPEGAPHFTLGYAFGLRVAPSPL 228
sp|Q9AGR3|SYFB_STAAU      GTAYEVAALYNTKMTKPETTSNELELSANDELTVTIENEDKVPYYSARVVHDVTIEPSPI 239
sp|Q4L5E4|SYFB_STAHJ      GTAYEVAALYQTEMTKPETQSNETSESATNELSVTIDNPEKVPYYSARVVKNVSIEPSPI 239
                          * * :: **  :  .:**:  :    :    :::.::: : .*:::   . .: : ***:
sp|Q5SGX1|SYFB_THET8      WMQRALFAAGMRPINNVVDVTNYVMLERAQPMHAFDLRFVGE-GIAVRRAREGERLKTLD 287
sp|Q9AGR3|SYFB_STAAU      WMQARLIKAGIRPINNVVDISNYVLLEYGQPLHMFDQDAIGSQQIVVRQANEGEKMTTLD 299
sp|Q4L5E4|SYFB_STAHJ      WVQARLIKAGIRPINNVVDISNYVLLEYGQPLHMFDQDHIGSKEIVVRQAKDEETMTTLD 299
                          *:*  *: **:********::***:** .**:* **   :*.  *.**:*.: * :.***
sp|Q5SGX1|SYFB_THET8      GVERTLHPEDLVIAGWRGEESFPLGLAGVMGGAESEVREDTEAIALEVACFDPVSIRKTA 347
sp|Q9AGR3|SYFB_STAAU      DTERELLTSDIVITN----GQTPIALAGVMGGDFSEVKEQTSNIVIEGAIFDPVSIRHTS 355
sp|Q4L5E4|SYFB_STAHJ      NNERKLVDTDIVISN----GQEPIALAGVMGGDFSEVTEQTTNVVIEGAIFDPVSIRHTS 355
                          . ** *   *:**:.     . *:.*******  *** *:*  :.:* * *******:*:
sp|Q5SGX1|SYFB_THET8      RRHGLRTEASHRFERGVDPLGQVPAQRRALSLLQALAGARVAEALLEAGSPK-PPEAIPF 406
sp|Q9AGR3|SYFB_STAAU      RRLNLRSESSSRFEKGIATEFVDEAVDRACYLLQTYANGKVLKDRVSSGELGAFITPIDI 415
sp|Q4L5E4|SYFB_STAHJ      RRLNLRSEASSRFEKGIATEFVDEAVDRACYLLQELASGEVLQDRVSSGDLGSFVTPIDI 415
                          ** .**:*:* ***:*:       *  **  ***  *...* :  :.:*.       * :
sp|Q5SGX1|SYFB_THET8      RPEYANRLLGTSYPEAEQIAILKRLGCRVEGEGPTYRVTPPSHRLDLRLEEDLVEEVARI 466
sp|Q9AGR3|SYFB_STAAU      TADKINRTIGFDLSQNDIVTIFNQLGFDTEINDDVITVLVPSRRKDITIKEDLIEEVARI 475
sp|Q4L5E4|SYFB_STAHJ      TAEKVNKTIGFNLSNDEIQSIFRQLGFETTLKGETLTVNVPSRRKDITIKEDLIEEVARI 475
                            :  *: :* .  : :  :*:.:**  .  :. .  *  **:* *: ::***:******
sp|Q5SGX1|SYFB_THET8      QGYETIPLALPAFFPAPDNRGVEAPYRKEQRLREVLSGLGFQEVYTYSFMDPEDARRFRL 526
sp|Q9AGR3|SYFB_STAAU      YGYDDIPSTLPVFDKVTSGQLTD-RQYKTRMVKEVLEGAGLDQAITYSLVSKEDATAFSM 534
sp|Q4L5E4|SYFB_STAHJ      YGYDEIPSSLPVFGEVTSGELTD-RQHKTRTLKETLEGAGLNQAITYSLVSKDHAKDFAL 534
                           **: ** :**.*  . ... .:    * : ::*.*.* *:::. ***::. :.*  * :
sp|Q5SGX1|SYFB_THET8      DP-PRLLLLNPLAPEKAALRTHLFPGLVRVLKENLDLDRPERALLFEVGRVFREREE--- 582
sp|Q9AGR3|SYFB_STAAU      QQRQTIDLLMPMSEAHASLRQSLLPHLIEVASYNVARK-NKDVKLFEIGNVFFANGEGEL 593
sp|Q4L5E4|SYFB_STAHJ      QERPTISLLMPMSEAHATLRQSLLPHLIEATAYNVARK-NKDVRLYEIGRVFFGNGEGEL 593
                          :    : ** *::  :*:**  *:* *:..   *:  .  : . *:*:*.**  . *   
sp|Q5SGX1|SYFB_THET8      ----THLAGLLFGEGVGLPWAKE-RLSGYFLLKGYLEALFARLGLAFRVEAQAFPFLHPG 637
sp|Q9AGR3|SYFB_STAAU      PDQVEYLSGILTGDYVVNQWQGKKETVDFYLAKGVVDRVSEKLNLEFSYRRADIDGLHPG 653
sp|Q4L5E4|SYFB_STAHJ      PDEVEYLSGILTGEYVVNAWQGKKEEIDFFIAKGVVDRVAEKLNLEFSYKAGKIEGLHPG 653
                               :*:*:* *: *   *  : .  .::: ** :: :  :*.* *  .   :  ****
sp|Q5SGX1|SYFB_THET8      VSGRVLVEGEEVGFLGALHPEIAQELELPPVHLFELRLP----LPDKPLAFQDPSRHPAA 693
sp|Q9AGR3|SYFB_STAAU      RTAEILLENKVVGFIGELHPTLAADNDLKRTYVFELNFDALMAVSVGYINYQPIPRFPGM 713
sp|Q4L5E4|SYFB_STAHJ      RTAIVSLEGQDIGFIGELHPQVAADNDLKRTYVFELNYDAMMQVAVGYINYEQIPKFPGV 713
                           :. : :*.: :**:* *** :* : :*  .::***.      :    : ::   :.*. 
sp|Q5SGX1|SYFB_THET8      FRDLAVVVPAPTPYGEVEALVREAAGPYLESLALFDLYQGPPLPEGHKSLAFHLRFRHPK 753
sp|Q9AGR3|SYFB_STAAU      SRDIALEVDQNIPAADLLSTIHAHGGNILKDTLVFDVYQGEHLEKGKKSIAIRLNYLDTE 773
sp|Q4L5E4|SYFB_STAHJ      TRDIALEVNHDVPSSELKQIIHNNGEDILQSTLVFDVYEGEHLEKGKKSVAIRLNYLDTE 773
                           **:*: *    * .::   ::  .   *:.  :**:*:*  * :*:**:*::*.: . :
       
sp|Q5SGX1|SYFB_THET8      RTLRDEEVEEAVSRVAEALRARGFGLRGLDTP 785
sp|Q9AGR3|SYFB_STAAU      ETLTDERVSKVQAEIEAALIEQGAVIR----- 800
sp|Q4L5E4|SYFB_STAHJ      DTLTDERVSKIHDKILEALQAQGATIR----- 800
** ** * ** * *
b8 C-terminal domain
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The tRNAphe sequence of S. aureus is available from the National Centre for Biotechnology 
Information (www.ncbi.nlm.gov). The tRNAphe sequence length for S. aureus and S. 
haemolyticus is 73 bases while T. thermophilus tRNAphe has 76 bases. Clustal Omega 1.2.3 for 
RNA (13), is utilized in alignment with tRNAphe for S. aureus, S. haemolyticus and T. 
thermophilus as the RNA alignment of these bases would reveal the most conserved nucleotides, 
specially for the anticodon (GAA) and CAA end playing a vital role in binding with PheRS (Fig. 
7). 
 
Figure 7 Genomic alignment of tRNAphe for S. aureus, S. haemolyticus and T. thermophilus, 
respectively, where boxed nucleotides are conserved GAA anticodon and CCA end. 
 
Anticodon (GAA) Recognition 
RNA fold (35) is a web server for predicting the RNA secondary structure accessible 
through http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi for anticipation of S. aurues tRNAphe 
secondary structure (Fig.8b). The T. thermophilus tRNAphe secondary structure (26) (Fig. 8a) is 
quite similar to the predicted one for S. aurues tRNAphe. In T. thermophilus, it was found (28) 
that G34 interacts with the largest number of amino acid residues as it makes stacking interaction 
with Tyr β* 731 (S. aureus Tyr β* 751) and two base specific interactions. The first one is 
between O6 G34 and Ser β* 742 (S. aureus Ser β* 762) and the second one is between N2 of 
G34 and Asp β* 729 (S. aureus Asp β* 749) in addition to a hydrogen bond between N7 of G34 
and Arg β*780 (S. aureus Arg β* 800). A35 interacts with Ala β*698 (S. aureus Ala β* 718) 
gi|88193823:c1864867-1864795     GGTTCAGTAGCTCAGTTGGTAGAGCAATGGATTGAAGCTCCATGTGTCGGCAGTTCGACT
gi|70725001:1140750-1140822      GGTTCAGTAGCTCAGTTGGTAGAGCAATGGATTGAAGCTCCATGTGTCGGCAGTTCGACT
gi|55979969:1311554-1311629      GCCGAGGTAGCTCAGTTGGTAGAGCATGCGACTGAAAATCGCAGTGTCGGCGGTTCGATT
                                 *     ********************   ** ****  **   ******** ****** *
gi|88193823:c1864867-1864795     CTGTCCT---GAACAA
gi|70725001:1140750-1140822      CTGTCCT---GAACCA
gi|55979969:1311554-1311629      CCGCCCCTCGGCACCA
                                 * * **    * ****
CLUSTAL O(1.2.3) multiple sequence alignment
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through a van der waals bond. A36 interacts with Leu β* 697 (S. aureus Ile β* 717) by van der 
waals and with Asp β*696 (S. aureus Asp β* 716) via a hydrogen bond. 
 
Figure 8 a: Cloverleaf representation of T. thermophilus tRNAPhe (26). b: predicted secondary 
structure of the S.aureus PheRS tRNAphe 
 
Binding with CCA end 
According to the ternary complex of  Thermus thermophilus PheRS.tRNAphe.PheOH-AMP (21), 
the CCA end interacts with the α-subunit active site and with the N-terminal domain of the β-
subunit for the same heterodimer. Table 8 shows proposed interactions of the CCA end in 
tRNAphe with S. aureus PheRS based on the clustal alignment of both α and β- subunits for T. 
thermophilus and S. aureus and also their genomic alignment of tRNAphe. 
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Table 8 Interactions of the CCA end in both S. aureus tRNAphe and T. thermophilus tRNAphe. 
CCA end in Thermus 
thermophilus 
Binding residues  
T .thermophilus 
CCA end in 
Staphylococcus aureus 
Binding residues in  
S. aureus 
A76 His α212 (motif 2) 
Arg α321 (motif 3) 
Arg α204 (motif 2) 
Met α148 
Glu α206 (motif 2) 
A73 His α208  (motif 2) 
Arg α318  (motif 3) 
Arg α200  (motif 2) 
Met α157 
Asp α202  (motif 2) 
C75 Glu β31   (β1) 
Asp β33   (β1) 
His β358  (β3) 
Arg β362  (β3) 
C72 Glu β31     (β1) 
Asp β33     (β1) 
Ser β366    (β3) 
Lys β370    (β3) 
C74 Arg β353  (β3) C71 Arg β361    (β3) 
    
Final constructed S. aureus PheS model 
The final constructed model of S. aureus PheS indicates the characteristic domains of aaRSs 
class II where the active site is built around antiparallel β sheets (Fig.9). The CCA end of 
tRNAphe interacts with the α-subunit active site and with the N-terminal domain of the β-subunit 
for the same heterodimer. However, the GAA anticodon tRNAphe is recognised by the β8 
domain, which is located at the C-terminal domain of the β*-subunit of the second heterodimer. 
The model has two metal binding sites, one for magnesium metal, which is present at the 
interface between the α and β-subunits near to the active site, essential for protein-protein 
interaction within the PheRS enzyme maintaining its activity in the aminoacylation process. The 
second one is a zinc finger where Cys267, Cys270, Cys275 and Cys278 make a tetrahedral 
coordination with zinc (Fig.8).  
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Figure 9 Final S. aureus PheS homology model with characteristic domains: α-active site 
(purple), CCA end of tRNAphe binding site (green), zinc finger (grey), magnesium binding region 
(orange) and outlier Gly272 (black). 
 
CONCLUSIONS 
A homology model for PheRS-α subunit has been developed using a multi-template approach 
and the constructed model has the characteristic features present in Class II aaRSs enzymes. 
Docking of phenylalanine, phenylalanyl-adenylate and known inhibitors in the generated model 
was used to validate the predicted active site through MOE docking procedures. The active site 
key residues in the model include Ala154, Ser174, Gln214, Glu216, Phe212, Phe256, Glu285 
and Gly288. Glu216 is considered as an anchor, directing the ligands into the correct orientation 
within the hydrophobic pocket. Asp β716, Ile β717, Ala β718, Aspβ749, Tyr β751, Ser β762 and 
Argβ800 are the predicted residues involved in the specific interactions between the protein and 
the tRNAphe anticodon (GAA), the corresponding residues in close homologous PheRS enzymes 
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are conserved at the C terminal of the beta subunit. The CCA end of tRNAphe interacts with the 
α-subunit active site and with the N-terminal domain of the β-subunit for the same heterodimer. 
The generated model has two metal binding sites for zinc and magnesium, the later one has an 
essential role in the binding between the different subunits of the enzyme enabling the enzyme 
activity. Identification of the whole model with its active binding sites and key binding residues 
serve as a crucial step in rational drug design for the development of new antibacterial agents. 
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